Join
Live feed
·
INSIDERFilingvia Quantisnow
Petros Pharmaceuticals Inc. logo

Director Walker Wayne Remell was granted 150,000 shares, increasing direct ownership by 1,804% to 158,314 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
PTPI· Petros Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PTPI (Petros Pharmaceuticals Inc.) and more on Quantisnow.